Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 11 of the 13 calendar months from Oct 2025 to Oct 2026: Oct 2025, Nov 2025, Dec 2025, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $475K (7,636 shares) of Cytokinetics Inc on Mar 17, 2026. Filing
- Last sale before this period: Oct 7, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Cytokinetics Inc (CYTK) | EVP Research & Development | Jun 8, 2012 | Oct 6, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 6, 2026, Cytokinetics Inc: sold 3,500 shares for $215K, under a disclosed plan; 3,500 shares acquired by exercising options. 1 filing: 1
- Sep 22, 2026, Cytokinetics Inc: sold 3,500 shares for $239K, under a disclosed plan; 3,500 shares acquired by exercising options. 1 filing: 1
- Sep 8, 2026, Cytokinetics Inc: sold 3,500 shares for $264K, under a disclosed plan; 3,500 shares acquired by exercising options. 1 filing: 1
- Aug 18, 2026, Cytokinetics Inc: sold 3,500 shares for $265K, under a disclosed plan; 3,500 shares acquired by exercising options. 1 filing: 1
- Jul 21, 2026, Cytokinetics Inc: sold 3,500 shares for $282K, under a disclosed plan; 3,500 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.